Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase vs Alteplase in Acute Ischemic Stroke (NOR-TEST 2)
NCT03854500Phase 3Terminated
- Sponsor
- Haukeland University Hospital
- Start
- Oct 2019
- Primary completion
- Sep 2021
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in ischemic stroke, sponsored by Haukeland University Hospital. Started Oct 2019; status: terminated.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03854500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03854500.